Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kobold

Showing results (31-40 of 177) with videos related to

Pageof 18
Sort By:
Acta Haematologica|March 13, 2010
Isolated limb perfusion with melphalan for the treatment of intractable primary cutaneous diffuse large B-cell lymphoma leg typeSebastian Kobold, Nerbil Killic, Tim Lütkens, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
FLT3 - ITD positive acute lymphocytic leukemia, does it impact on disease´s course?Sebastian Kobold, Nerbil Kılıç, John Scharlau, et al.
Seminars in Immunopathology|September 27, 2022
Beyond direct killing-novel cellular immunotherapeutic strategies to reshape the tumor microenvironmentDuc Huynh, Pia Winter, Florian Märkl, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 25, 2026
The role of cytokines in cytokine release syndrome (CRS) after CAR T cell therapyKathrin Gabriel, Lucie Heinzerling, Louisa von Baumgarten, et al.
Translational Oncology|May 29, 2021
Long non-coding RNAs in cancer stem cellsMelanie Schwerdtfeger, Vincenzo Desiderio, Sebastian Kobold, et al.
Oncotarget|January 11, 2014
The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma modelSebastian Kobold, Melanie Merk, Luisa Hofer, et al.
Expert Opinion on Investigational Drugs|February 4, 2022
Novel systemic treatment approaches for metastatic pancreatic cancerKlara Dorman, Volker Heinemann, Sebastian Kobold, et al.
Deutsches Arzteblatt International|December 16, 2015
Immunotherapy in TumorsSebastian Kobold, Peter Duewell, Max Schnurr, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 21, 2022
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor modelsStefanie Lesch, Alessia Nottebrock, Felicitas Rataj, et al.
British Journal of Cancer|November 11, 2018
Teaching an old dog new tricks: next-generation CAR T cellsNicholas Tokarew, Justyna Ogonek, Stefan Endres, et al.
Pageof 18

Showing results (31-40 of 177) with videos related to

Sort By:
Pageof 18
Acta Haematologica|March 13, 2010
Isolated limb perfusion with melphalan for the treatment of intractable primary cutaneous diffuse large B-cell lymphoma leg typeSebastian Kobold, Nerbil Killic, Tim Lütkens, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
FLT3 - ITD positive acute lymphocytic leukemia, does it impact on disease´s course?Sebastian Kobold, Nerbil Kılıç, John Scharlau, et al.
Seminars in Immunopathology|September 27, 2022
Beyond direct killing-novel cellular immunotherapeutic strategies to reshape the tumor microenvironmentDuc Huynh, Pia Winter, Florian Märkl, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|January 25, 2026
The role of cytokines in cytokine release syndrome (CRS) after CAR T cell therapyKathrin Gabriel, Lucie Heinzerling, Louisa von Baumgarten, et al.
Translational Oncology|May 29, 2021
Long non-coding RNAs in cancer stem cellsMelanie Schwerdtfeger, Vincenzo Desiderio, Sebastian Kobold, et al.
Oncotarget|January 11, 2014
The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma modelSebastian Kobold, Melanie Merk, Luisa Hofer, et al.
Expert Opinion on Investigational Drugs|February 4, 2022
Novel systemic treatment approaches for metastatic pancreatic cancerKlara Dorman, Volker Heinemann, Sebastian Kobold, et al.
Deutsches Arzteblatt International|December 16, 2015
Immunotherapy in TumorsSebastian Kobold, Peter Duewell, Max Schnurr, et al.
Cellular Oncology (Dordrecht, Netherlands)|November 21, 2022
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T cells in preclinical solid tumor modelsStefanie Lesch, Alessia Nottebrock, Felicitas Rataj, et al.
British Journal of Cancer|November 11, 2018
Teaching an old dog new tricks: next-generation CAR T cellsNicholas Tokarew, Justyna Ogonek, Stefan Endres, et al.
Pageof 18